Scibetta James S
Insider CIK 1383242 · NEPH.OB Director · PCRX SVP, Chief Financial Officer · AQST Director · MTNB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MTNB Matinas BioPharma Holdings | A Award deriv | 2023-11-01 | 2023-11-03 | 437,244 | — | $0 | 437,244 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award deriv | 2022-11-14 | 2022-11-16 | 142,657 | — | $0 | 142,657 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award deriv | 2021-11-01 | 2021-11-02 | 90,882 | — | $0 | 90,882 | SEC↗ |
| MTNB Matinas BioPharma Holdings | C Conversion deriv | 2021-06-19 | 2021-06-24 | 12 | — | $0 | 0 | SEC↗ |
| MTNB Matinas BioPharma Holdings | J Other | 2021-06-19 | 2021-06-24 | 4,800 | — | $0 | 625,958 | SEC↗ |
| MTNB Matinas BioPharma Holdings | C Conversion | 2021-06-19 | 2021-06-24 | 24,000 | — | $0 | 649,958 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2021-06-15 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award deriv | 2020-11-02 | 2020-11-10 | 122,605 | — | $0 | 122,605 | SEC↗ |
| MTNB Matinas BioPharma Holdings | J Other | 2020-06-23 | 2020-06-24 | 3,600 | — | $0 | 621,158 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2020-06-16 | 2020-06-18 | 14,000 | — | $0 | 14,000 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2019-12-31 | 2020-01-03 | 8,260 | — | $0 | 617,558 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award deriv | 2019-11-01 | 2019-11-05 | 107,416 | — | $0 | 107,416 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2019-09-30 | 2019-10-02 | 29,739 | — | $0 | 606,898 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2019-08-21 | 2019-08-22 | 900 | $3.81 | $3.4K | 31,635 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2019-08-20 | 2019-08-22 | 11,310 | $3.80 | $43.0K | 30,735 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2019-08-19 | 2019-08-22 | 10,761 | $3.77 | $40.6K | 19,425 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2019-06-30 | 2019-07-02 | 21,879 | — | $0 | 577,159 | SEC↗ |
| MTNB Matinas BioPharma Holdings | J Other | 2019-06-21 | 2019-10-02 | 2,400 | — | $0 | 609,298 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2019-06-13 | 2019-06-17 | 13,350 | — | $0 | 13,350 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2019-03-31 | 2019-04-03 | 17,202 | — | $0 | 555,280 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2018-12-31 | 2019-01-04 | 31,513 | — | $0 | 538,078 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award deriv | 2018-11-01 | 2018-11-05 | 128,299 | — | $0 | 128,299 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award deriv | 2018-11-01 | 2018-11-05 | 128,299 | — | $0 | 128,299 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2018-10-01 | 2018-10-03 | 20,381 | — | $0 | 506,565 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2018-07-24 | 2018-07-26 | 26,700 | — | $0 | 26,700 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2018-06-29 | 2018-07-11 | 43,203 | — | $0 | 486,184 | SEC↗ |
| MTNB Matinas BioPharma Holdings | P Buy deriv | 2018-06-21 | 2018-06-22 | 12 | $1000.00 | $12.0K | 12 | SEC↗ |
| MTNB Matinas BioPharma Holdings | A Award | 2018-03-30 | 2018-04-02 | 24,672 | — | $0 | 442,981 | SEC↗ |
| MTNB Matinas BioPharma Holdings | P Buy | 2017-09-07 | 2017-09-07 | 5,000 | $1.29 | $6.5K | 418,309 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2017-06-05 | 2017-06-07 | 1,966 | $43.32 | $85.2K | 25,118 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2017-05-15 | 2017-05-17 | 20,000 | — | $0 | 15,251 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2017-05-15 | 2017-05-17 | 20,000 | $5.49 | $109.8K | 47,084 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2017-05-15 | 2017-05-17 | 20,000 | $51.20 | $1.02M | 27,084 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2017-01-17 | 2017-01-19 | 17,627 | — | $0 | 35,251 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2017-01-17 | 2017-01-19 | 2,373 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2017-01-17 | 2017-01-19 | 17,627 | $5.49 | $96.8K | 47,084 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2017-01-17 | 2017-01-19 | 15,003 | $38.39 | $576.0K | 32,081 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2017-01-17 | 2017-01-19 | 2,373 | $1.61 | $3.8K | 29,457 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2017-01-17 | 2017-01-19 | 4,997 | $38.97 | $194.7K | 27,084 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2016-12-07 | 2016-12-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2016-11-15 | 2016-11-17 | 20,000 | — | $0 | 2,373 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2016-11-15 | 2016-11-17 | 20,000 | $1.61 | $32.2K | 47,084 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2016-11-15 | 2016-11-17 | 20,000 | $36.50 | $730.0K | 27,084 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2016-08-15 | 2016-08-17 | 15,877 | — | $0 | 22,373 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2016-08-15 | 2016-08-17 | 9,123 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2016-08-15 | 2016-08-17 | 9,123 | $1.61 | $14.7K | 36,207 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2016-08-15 | 2016-08-17 | 25,000 | $45.21 | $1.13M | 27,084 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2016-08-15 | 2016-08-17 | 15,877 | $1.61 | $25.6K | 52,084 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2016-06-15 | 2016-06-17 | 32,500 | — | $0 | 32,500 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award | 2016-06-15 | 2016-06-17 | 16,250 | — | $0 | 26,754 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2015-11-03 | 2015-11-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | P Buy | 2015-09-11 | 2015-09-14 | 5,000 | $61.37 | $306.9K | 10,504 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2015-02-06 | 2015-02-09 | 15,000 | — | $0 | 38,250 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2015-02-06 | 2015-02-09 | 5,904 | $111.11 | $656.0K | 10,033 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2015-02-06 | 2015-02-09 | 3,103 | $111.98 | $347.5K | 6,930 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2015-02-06 | 2015-02-09 | 15,000 | $1.61 | $24.1K | 20,230 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2015-02-06 | 2015-02-09 | 4,293 | $110.17 | $473.0K | 15,937 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2015-02-06 | 2015-02-09 | 1,700 | $112.91 | $191.9K | 5,230 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2014-11-07 | 2014-11-12 | 15,000 | — | $0 | 53,250 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-11-07 | 2014-11-12 | 8,600 | $86.99 | $748.1K | 9,100 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-11-07 | 2014-11-12 | 800 | $89.56 | $71.6K | 5,200 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-11-07 | 2014-11-12 | 3,100 | $87.65 | $271.7K | 6,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-11-07 | 2014-11-12 | 200 | $90.33 | $18.1K | 5,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-11-07 | 2014-11-12 | 2,300 | $86.13 | $198.1K | 17,700 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2014-11-07 | 2014-11-12 | 15,000 | $1.61 | $24.1K | 20,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2014-08-08 | 2014-08-11 | 6,134 | — | $0 | 68,250 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2014-08-08 | 2014-08-11 | 8,866 | — | $0 | 9,123 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-08-08 | 2014-08-11 | 5,000 | $99.22 | $496.1K | 15,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2014-08-08 | 2014-08-11 | 8,866 | $1.61 | $14.3K | 13,866 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-08-08 | 2014-08-11 | 10,000 | $99.83 | $998.3K | 5,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2014-08-08 | 2014-08-11 | 6,134 | $1.61 | $9.9K | 20,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2014-06-03 | 2014-06-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2014-05-08 | 2014-05-09 | 15,000 | — | $0 | 17,989 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2014-05-08 | 2014-05-09 | 15,000 | $1.61 | $24.1K | 20,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-05-08 | 2014-05-09 | 3,300 | $74.27 | $245.1K | 16,700 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-05-08 | 2014-05-09 | 300 | $75.80 | $22.7K | 5,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-05-08 | 2014-05-09 | 11,400 | $75.25 | $857.9K | 5,300 | SEC↗ |
| NEPH NEPHROS INC | A Award deriv | 2013-12-31 | 2014-01-07 | 60,440 | — | $0 | 60,440 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2013-12-30 | 2014-01-02 | 10,000 | — | $0 | 32,989 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-12-30 | 2014-01-02 | 10,000 | $55.55 | $555.5K | 5,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2013-12-30 | 2014-01-02 | 10,000 | $1.61 | $16.1K | 15,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2013-09-30 | 2013-10-02 | 10,000 | — | $0 | 42,989 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2013-09-30 | 2013-10-02 | 10,000 | $1.61 | $16.1K | 15,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-09-30 | 2013-10-02 | 10,000 | $46.74 | $467.4K | 5,000 | SEC↗ |
| NEPH NEPHROS INC | A Award | 2013-08-20 | 2013-08-22 | 12,078 | — | $0 | 64,134 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2013-06-28 | 2013-07-02 | 10,000 | — | $0 | 52,989 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-06-28 | 2013-07-02 | 10,000 | $28.05 | $280.5K | 5,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2013-06-28 | 2013-07-02 | 10,000 | $1.61 | $16.1K | 15,000 | SEC↗ |
| NEPH NEPHROS INC | A Award deriv | 2013-05-23 | 2013-06-11 | 12,500 | — | $0 | 12,500 | SEC↗ |
| NEPH NEPHROS INC | A Award | 2013-05-23 | 2013-06-11 | 52,056 | — | $0 | 52,056 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2013-03-28 | 2013-04-01 | 10,000 | — | $0 | 62,989 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2013-03-28 | 2013-04-01 | 10,000 | $1.61 | $16.1K | 15,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-28 | 2013-04-01 | 10,000 | $28.49 | $284.9K | 5,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2012-06-05 | 2012-06-07 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NEPH.OB NEPHROS INC | A Award deriv | 2012-02-16 | 2012-03-20 | 12,500 | — | $0 | 12,500 | SEC↗ |